LIVE FROM SEC EDGAR
Every SEC filing that moves stocks, the minute it lands.
Earnings, insider buys and sells, 5% stakes, IPO filings and red flags, summarized in plain English.
8-KInsider
5% stakeIPORed flag
center = newest
Filings per hour last 24 hours
Braveheart Bio, Inc.BRVE · Nov 6, 3:17 PM ET
Braveheart Bio reports 52-week HCM drug extension data; 79% reach gradient target
Braveheart Bio and Hengrui Pharma presented 52-week open-label extension data for HRS/BHB-1893 in 42 obstructive HCM patients, with 79% achieving a Valsalva LVOT gradient below 30 mmHg at Week 52.
AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.